| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 3.32e-04 | 473 | 40 | 6 | GO:0004842 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 5.05e-04 | 512 | 40 | 6 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 6.18e-04 | 532 | 40 | 6 | GO:0016755 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 7.86e-04 | 775 | 40 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 8.41e-04 | 372 | 40 | 5 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.14e-03 | 398 | 40 | 5 | GO:0061659 | |
| GeneOntologyBiologicalProcess | positive regulation of hemostasis | 2.66e-07 | 31 | 37 | 4 | GO:1900048 | |
| GeneOntologyBiologicalProcess | positive regulation of blood coagulation | 2.66e-07 | 31 | 37 | 4 | GO:0030194 | |
| GeneOntologyBiologicalProcess | positive regulation of coagulation | 3.91e-07 | 34 | 37 | 4 | GO:0050820 | |
| GeneOntologyBiologicalProcess | positive regulation of wound healing | 8.73e-06 | 73 | 37 | 4 | GO:0090303 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 2.09e-05 | 91 | 37 | 4 | GO:0030193 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 2.28e-05 | 93 | 37 | 4 | GO:1903036 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 2.28e-05 | 93 | 37 | 4 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 2.59e-05 | 96 | 37 | 4 | GO:0050818 | |
| GeneOntologyBiologicalProcess | protein polyubiquitination | 1.57e-04 | 289 | 37 | 5 | GO:0000209 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 2.17e-04 | 166 | 37 | 4 | GO:0061041 | |
| GeneOntologyBiologicalProcess | negative regulation of fibrinolysis | 2.81e-04 | 14 | 37 | 2 | GO:0051918 | |
| GeneOntologyBiologicalProcess | regulation of fibrinolysis | 5.25e-04 | 19 | 37 | 2 | GO:0051917 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 5.99e-04 | 217 | 37 | 4 | GO:1903034 | |
| Domain | - | 3.50e-05 | 449 | 39 | 7 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 4.03e-05 | 459 | 39 | 7 | IPR013083 | |
| Domain | zf-C3HC4 | 9.60e-05 | 223 | 39 | 5 | PF00097 | |
| Domain | ZF_RING_1 | 3.31e-04 | 291 | 39 | 5 | PS00518 | |
| Domain | Znf_RING_CS | 3.62e-04 | 163 | 39 | 4 | IPR017907 | |
| Domain | ZF_RING_2 | 3.69e-04 | 298 | 39 | 5 | PS50089 | |
| Domain | RING | 4.10e-04 | 305 | 39 | 5 | SM00184 | |
| Domain | Znf_C3HC4_RING-type | 4.44e-04 | 172 | 39 | 4 | IPR018957 | |
| Domain | Znf_RING | 5.56e-04 | 326 | 39 | 5 | IPR001841 | |
| Domain | Kringle | 5.66e-04 | 17 | 39 | 2 | IPR000001 | |
| Domain | Kringle | 5.66e-04 | 17 | 39 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 5.66e-04 | 17 | 39 | 2 | PS00021 | |
| Domain | Kringle_CS | 5.66e-04 | 17 | 39 | 2 | IPR018056 | |
| Domain | KR | 5.66e-04 | 17 | 39 | 2 | SM00130 | |
| Domain | KRINGLE_2 | 5.66e-04 | 17 | 39 | 2 | PS50070 | |
| Domain | Znf_B-box | 6.42e-04 | 81 | 39 | 3 | IPR000315 | |
| Domain | Kringle-like | 2.03e-03 | 32 | 39 | 2 | IPR013806 | |
| Domain | Znf-RING_LisH | 2.29e-03 | 34 | 39 | 2 | IPR027370 | |
| Domain | zf-RING_UBOX | 2.29e-03 | 34 | 39 | 2 | PF13445 | |
| Domain | PRY | 3.47e-03 | 42 | 39 | 2 | PF13765 | |
| Domain | PRY | 4.51e-03 | 48 | 39 | 2 | SM00589 | |
| Domain | PRY | 4.51e-03 | 48 | 39 | 2 | IPR006574 | |
| Domain | Butyrophylin | 9.38e-03 | 70 | 39 | 2 | IPR003879 | |
| Domain | - | 9.64e-03 | 71 | 39 | 2 | 4.10.45.10 | |
| Domain | ConA-like_dom | 1.07e-02 | 219 | 39 | 3 | IPR013320 | |
| Domain | ZF_BBOX | 1.21e-02 | 80 | 39 | 2 | PS50119 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 9.63e-06 | 23 | 26 | 3 | MM15936 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 2.13e-04 | 12 | 26 | 2 | MM1398 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.94e-04 | 14 | 26 | 2 | MM1458 | |
| Pathway | REACTOME_DISSOLUTION_OF_FIBRIN_CLOT | 3.38e-04 | 15 | 26 | 2 | MM15450 | |
| Pubmed | Lactational competence and involution of the mouse mammary gland require plasminogen. | 3.87e-06 | 3 | 40 | 2 | 11003846 | |
| Pubmed | Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. | 3.87e-06 | 3 | 40 | 2 | 12431907 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 15743790 | ||
| Pubmed | Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. | 3.87e-06 | 3 | 40 | 2 | 11929773 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 8179996 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 28336948 | ||
| Pubmed | Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice. | 7.73e-06 | 4 | 40 | 2 | 21931850 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 19210287 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 21704601 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 12911578 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 11404420 | ||
| Pubmed | Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator. | 7.73e-06 | 4 | 40 | 2 | 16554301 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 21326869 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 18042398 | ||
| Pubmed | Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. | 7.73e-06 | 4 | 40 | 2 | 16763560 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 19286661 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 15161662 | ||
| Pubmed | Early embryonic expression of murine coagulation system components. | 8.23e-06 | 34 | 40 | 3 | 11154109 | |
| Pubmed | The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. | 1.29e-05 | 5 | 40 | 2 | 11818362 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 11306532 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 18957535 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 12657615 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 10880388 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 31819012 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 12875972 | ||
| Pubmed | Soluble M6P/IGF2R released by TACE controls angiogenesis via blocking plasminogen activation. | 1.29e-05 | 5 | 40 | 2 | 21273553 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 10318667 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 21292167 | ||
| Pubmed | Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. | 1.93e-05 | 6 | 40 | 2 | 15841177 | |
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 25893677 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 32878247 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 9438420 | ||
| Pubmed | 4.10e-05 | 167 | 40 | 4 | 22159717 | ||
| Pubmed | Hemostatic gene polymorphisms in young Sardinian with non-fatal acute myocardial infarction. | 5.77e-05 | 10 | 40 | 2 | 20036902 | |
| Pubmed | A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo. | 7.05e-05 | 11 | 40 | 2 | 26647393 | |
| Pubmed | Direct activation of protein kinases by unanchored polyubiquitin chains. | 9.98e-05 | 13 | 40 | 2 | 19675569 | |
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | 1.78e-04 | 460 | 40 | 5 | 20562862 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.81e-04 | 95 | 40 | 3 | 29643511 | |
| Pubmed | 2.44e-04 | 105 | 40 | 3 | 22493164 | ||
| Pubmed | Tissue-Specific Gain of RTK Signalling Uncovers Selective Cell Vulnerability during Embryogenesis. | 3.80e-04 | 25 | 40 | 2 | 26393505 | |
| Pubmed | Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. | 6.78e-04 | 149 | 40 | 3 | 19549727 | |
| Pubmed | 7.32e-04 | 153 | 40 | 3 | 25037231 | ||
| Pubmed | 1.08e-03 | 175 | 40 | 3 | 28071719 | ||
| Pubmed | 1.13e-03 | 43 | 40 | 2 | 20565774 | ||
| GeneFamily | Ring finger proteins | 6.91e-05 | 275 | 29 | 5 | 58 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.01e-02 | 95 | 29 | 2 | 59 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.88e-06 | 146 | 40 | 4 | 7748277cf2f12e2930d4f5a22247ab9bc266a954 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-05 | 186 | 40 | 4 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-05 | 186 | 40 | 4 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 187 | 40 | 4 | ddfc2d1d9fcc3d8e4d3d015576bb17eebf44ada9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 189 | 40 | 4 | a48df46274d51e84ffb40264646de7346104efb9 | |
| Disease | Thromboembolism | 1.00e-04 | 12 | 37 | 2 | C0040038 | |
| Disease | Deep Vein Thrombosis | 3.16e-04 | 21 | 37 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 3.16e-04 | 21 | 37 | 2 | C0042487 | |
| Disease | Coronary heart disease | 4.15e-04 | 24 | 37 | 2 | C0010068 | |
| Disease | renal cell carcinoma (is_marker_for) | 5.56e-04 | 128 | 37 | 3 | DOID:4450 (is_marker_for) | |
| Disease | lumbar disc degeneration | 5.67e-04 | 28 | 37 | 2 | EFO_0004994 | |
| Disease | Cardiovascular Diseases | 9.38e-04 | 36 | 37 | 2 | C0007222 | |
| Disease | atherosclerosis (is_marker_for) | 9.91e-04 | 37 | 37 | 2 | DOID:1936 (is_marker_for) | |
| Disease | end stage renal disease (is_implicated_in) | 1.22e-03 | 41 | 37 | 2 | DOID:783 (is_implicated_in) | |
| Disease | end stage renal disease (is_marker_for) | 1.53e-03 | 46 | 37 | 2 | DOID:783 (is_marker_for) | |
| Disease | Thrombus | 1.53e-03 | 46 | 37 | 2 | C0087086 | |
| Disease | Thrombosis | 1.73e-03 | 49 | 37 | 2 | C0040053 | |
| Disease | monokine induced by gamma interferon measurement | 1.95e-03 | 52 | 37 | 2 | EFO_0008236 | |
| Disease | Acute Cerebrovascular Accidents | 2.10e-03 | 54 | 37 | 2 | C0751956 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERYVPRASYFQCVQR | 36 | P30281 | |
| VRIRPTRPFCFFNCY | 421 | Q6NUN0 | |
| PPVYCVCRQPYDVNR | 36 | Q6ZMT4 | |
| CCRARPEAYQVPASY | 216 | Q9BYM8 | |
| IFLERYCFRPSYQCP | 1256 | Q9Y2I7 | |
| ISQPYVVCRQCPEYR | 421 | Q96EP1 | |
| CYPTQDTRGRLCPYF | 96 | Q9H5Z6 | |
| YCRGLPTVRPCNNYC | 256 | Q9Y625 | |
| LCLSCQDEAPYRPYQ | 181 | O95500 | |
| DRLNPGCFYRLRVYC | 626 | Q9Y2H6 | |
| CRSQEYRIGRCPNTY | 41 | Q8WTQ1 | |
| CRNPDAVAAPYCYTR | 191 | P08519 | |
| CRNPDAVAAPYCYTR | 761 | P08519 | |
| PDIYCPRETRYCYTQ | 66 | Q86Y78 | |
| YRPACYRPCYSILRR | 421 | A8MUX0 | |
| RYNPRYCKGDCPRAV | 376 | O60383 | |
| TRDECFARRAPYPNY | 391 | Q16610 | |
| CPSALVYRVNFRPRY | 81 | Q9BXX0 | |
| APHYNSCCRRKYRPE | 121 | Q9BWG6 | |
| YQQVCARYRALCVPP | 251 | Q3KNS1 | |
| YCRNPDNRRRPWCYV | 121 | P00749 | |
| ECQICFNYYSPRRRP | 11 | Q8N8N0 | |
| RYACRILCDRRPPYT | 186 | Q8N2H9 | |
| YCYRVNRRLFPVPVD | 241 | Q5JXC2 | |
| CCYLYRRRQQLQSPF | 111 | Q96DD7 | |
| VPCCQQLSRFNRYYS | 846 | O60287 | |
| CYRYRCAARSQNTPD | 341 | Q8NBK3 | |
| QPFLCCYRTEPYRRL | 351 | Q7Z7M1 | |
| YNRFGRCNRGERCPY | 676 | Q8IXZ2 | |
| PLPYLRNCRYDVCSC | 601 | P04275 | |
| RAERYNIEPSLYCPF | 366 | Q99797 | |
| SPYLCPQCRAVYQAR | 46 | Q14258 | |
| RPYRCQQCGRGYRHP | 46 | O15015 | |
| CPVCSRCYPNLAAYR | 1081 | O15015 | |
| ICYDPRRFYVCPAVL | 326 | Q495X7 | |
| DPDYIQCPYCQRRFN | 116 | Q96GY0 | |
| QPARYTCPRCNAPYC | 16 | Q9UHR6 | |
| ICSCFYPEPRNINIY | 21 | Q93045 | |
| PRNYPTAKYTCRLCD | 236 | Q5VYS8 | |
| QRPYPCPECDKTFRY | 271 | Q6IV72 | |
| ERPYQCPQCGRTFNR | 491 | Q6ZMS7 | |
| RRPGCYAYRQNPEAI | 16 | Q6NSJ0 |